Our Community
Latest Photos
Latest Videos
Our Blog
Forum
Latest Events
CLOSE

About Lindsay Rosenwald

Lindsay Rosenwald /Basic Information

  • Gender

  • Birthdate

    04-16
  • About Lindsay Rosenwald

    Dr. Lindsay A. Rosenwald is a well-known entrepreneur dedicated to medical advancements in biotechnology and clinical research. He has emerged as one of the most prolific and successful investors in the biotechnology industry over the last 20 years. Throughout his career, Dr. Rosenwald has developed and financed more than 50 companies, while acquiring more than 100 experimental medicines.

    Dr. Lindsay Rosenwald recently sold his company Cougar Biotechnology to Johnson & Johnson for nearly $1 billion. Cougar Biotechnology is a clinical trials firm with a particular focus on prostate cancer. Companies directed by Dr. Rosenwald are currently testing more than two dozen oncology drugs.

    Dr. Lindsay Rosenwald was responsible for overseeing the development of TRISENOX®, now marketed worldwide to thousands of leukemia sufferers. Dr. Rosenwald’s latest endeavor is his health-care investment firm Investment Partnership, co-founded with a business partner. The company invests in the health-care industry, most notably in biotechnology and life sciences.

    In 1977, Dr. Lindsay Rosenwald earned a Bachelor of Science in finance from Pennsylvania State University. He then attended Temple University School of Medicine, where he received his Doctorate of Medicine in 1983. In recognition of his knowledge and success, Dr. Rosenwald has received numerous awards and accolades. The online publication Genetic Engineering & Biotechnology News previously ranked Dr. Rosenwald as No. 1 on its list of Molecular Millionaires.

    Dr. Lindsay Rosenwald has instituted his own philanthropic foundation, which subsidizes both research and development ventures in the life sciences, pharmaceutical and biotechnology fields. A Board of Visitors member with Pennsylvania State University’s Smeal College of Business, he remains active in a variety of charitable organizations.
  • Languages Spoken

Lindsay Rosenwald /Contact Information

Lindsay Rosenwald /Education

Connections

    No Connections yet
Lindsay Rosenwald
Lindsay Rosenwald - We have a better diagnostic technology today - way more advanced than even 10 years ago.
- 8 months ago
  • Lindsay Rosenwald Member since
    Friday, 30 August 2013 09:53
  • Lindsay Rosenwald Last online
    8 months ago
  • Lindsay Rosenwald Profile views
    3,413 views

About Lindsay Rosenwald

Lindsay Rosenwald /Basic Information

  • Gender

  • Birthdate

    04-16
  • About Lindsay Rosenwald

    Dr. Lindsay A. Rosenwald is a well-known entrepreneur dedicated to medical advancements in biotechnology and clinical research. He has emerged as one of the most prolific and successful investors in the biotechnology industry over the last 20 years. Throughout his career, Dr. Rosenwald has developed and financed more than 50 companies, while acquiring more than 100 experimental medicines.

    Dr. Lindsay Rosenwald recently sold his company Cougar Biotechnology to Johnson & Johnson for nearly $1 billion. Cougar Biotechnology is a clinical trials firm with a particular focus on prostate cancer. Companies directed by Dr. Rosenwald are currently testing more than two dozen oncology drugs.

    Dr. Lindsay Rosenwald was responsible for overseeing the development of TRISENOX®, now marketed worldwide to thousands of leukemia sufferers. Dr. Rosenwald’s latest endeavor is his health-care investment firm Investment Partnership, co-founded with a business partner. The company invests in the health-care industry, most notably in biotechnology and life sciences.

    In 1977, Dr. Lindsay Rosenwald earned a Bachelor of Science in finance from Pennsylvania State University. He then attended Temple University School of Medicine, where he received his Doctorate of Medicine in 1983. In recognition of his knowledge and success, Dr. Rosenwald has received numerous awards and accolades. The online publication Genetic Engineering & Biotechnology News previously ranked Dr. Rosenwald as No. 1 on its list of Molecular Millionaires.

    Dr. Lindsay Rosenwald has instituted his own philanthropic foundation, which subsidizes both research and development ventures in the life sciences, pharmaceutical and biotechnology fields. A Board of Visitors member with Pennsylvania State University’s Smeal College of Business, he remains active in a variety of charitable organizations.
  • Languages Spoken

Lindsay Rosenwald /Contact Information

Lindsay Rosenwald /Education

Connections

    No Connections yet

Popular Members

Lindsay RosenwaldAldo DisorboDr. Hicham RibaDerrick StraussArnoldsainoAndrew Stolper